- Home
- DLTH vs ADAP Comparison
DLTH vs ADAP Comparison
Compare DLTH & ADAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLTH
- ADAP
- Stock Information
- Founded
- DLTH 1989
- ADAP 2008
- Country
- DLTH United States
- ADAP United Kingdom
- Employees
- DLTH N/A
- ADAP N/A
- Industry
- DLTH Clothing/Shoe/Accessory Stores
- ADAP Biotechnology: Pharmaceutical Preparations
- Sector
- DLTH Consumer Discretionary
- ADAP Health Care
- Exchange
- DLTH Nasdaq
- ADAP Nasdaq
- Market Cap
- DLTH 71.0M
- ADAP 75.5M
- IPO Year
- DLTH 2015
- ADAP 2015
- Fundamental
- Price
- DLTH $2.09
- ADAP $0.27
- Analyst Decision
- DLTH Hold
- ADAP Buy
- Analyst Count
- DLTH 1
- ADAP 6
- Target Price
- DLTH $2.75
- ADAP $1.35
- AVG Volume (30 Days)
- DLTH 38.7K
- ADAP 648.3K
- Earning Date
- DLTH 08-28-2025
- ADAP 08-11-2025
- Dividend Yield
- DLTH N/A
- ADAP N/A
- EPS Growth
- DLTH N/A
- ADAP N/A
- EPS
- DLTH N/A
- ADAP N/A
- Revenue
- DLTH $612,649,000.00
- ADAP $179,639,000.00
- Revenue This Year
- DLTH N/A
- ADAP N/A
- Revenue Next Year
- DLTH N/A
- ADAP $35.48
- P/E Ratio
- DLTH N/A
- ADAP N/A
- Revenue Growth
- DLTH N/A
- ADAP 878.53
- 52 Week Low
- DLTH $1.58
- ADAP $0.20
- 52 Week High
- DLTH $4.50
- ADAP $1.48
- Technical
- Relative Strength Index (RSI)
- DLTH 51.30
- ADAP 56.59
- Support Level
- DLTH $2.01
- ADAP $0.23
- Resistance Level
- DLTH $2.33
- ADAP $0.28
- Average True Range (ATR)
- DLTH 0.11
- ADAP 0.02
- MACD
- DLTH 0.01
- ADAP 0.00
- Stochastic Oscillator
- DLTH 42.86
- ADAP 87.96
About DLTH Duluth Holdings Inc. Class B
Duluth Holdings Inc is an apparel brand in the United States. The company offers shirts, pants, and casual wear for men and women under brands like Alaskan Hardgear, Armachillo, Ballroom, Cab Commander, Crouch Gusset, Dry on the Fly, Duluth Trading Co, Duluthflex, Fire Hose, Longtail T, No Polo Shirt, No Yank, Wild Boar, and others. The Company's revenue consists of the sale of apparel, footwear, and hard goods. The company operates in a single operating segment.
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.